Physician profile
Vanessa Collazo
NPI 1336446228
$1,064.12
in general payments reported to CMS, 2019-2025
9 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $125 · 2023: $170 · 2024: $486 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $500.23 | 2023-2025 | |
| Smith+Nephew, INC. | $229.04 | 2022-2024 | Renasys Touch, Pico 14 |
| Solventum Corporation | $120.46 | 2024 | V.A.C. Veraflo, Prevena |
| Celgene Corporation | $91.66 | 2021 | |
| Amgen INC. | $44.30 | 2024 | Uplizna |
| Bayer Healthcare Pharmaceuticals INC. | $22.41 | 2021 | |
| Glaxosmithkline, LLC. | $20.99 | 2025 | Benlysta |
| Boston Scientific Corporation | $18.36 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Collazo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.